CAS 1258392-53-8: AZD-5582
Description:AZD-5582 is a small molecule inhibitor primarily developed for its potential therapeutic applications in cancer treatment. It functions as a potent antagonist of the MDM2 protein, which is known for its role in regulating the p53 tumor suppressor pathway. By inhibiting MDM2, AZD-5582 aims to restore p53 activity, leading to increased apoptosis in cancer cells. The compound has been studied for its efficacy in various malignancies, particularly those with p53 mutations or dysregulation. AZD-5582 is characterized by its specific binding affinity to MDM2, which is crucial for its mechanism of action. Additionally, it has been evaluated in preclinical and clinical settings for its pharmacokinetic properties, safety profile, and potential to enhance the effectiveness of other anticancer therapies. As a research compound, AZD-5582 represents a promising avenue in targeted cancer therapy, particularly in the context of personalized medicine approaches that leverage the status of the p53 pathway in tumors.
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AZD5582 REF: TM-T14378CAS: 1258392-53-8 | 98.75% | To inquire | Tue 22 Apr 25 |
 | AZD 5582 REF: 3D-IAC39253CAS: 1258392-53-8 | Min. 95% | To inquire | Thu 29 May 25 |
 | AZD 5582 REF: IN-DA009CGXCAS: 1258392-53-8 | 98% | - - - | Discontinued product |
AZD5582
Ref: TM-T14378
| 1mg | 54.00 € |
AZD 5582
Ref: 3D-IAC39253
| 25mg | 926.00 € | ||
| 50mg | 1,215.00 € | ||
| 100mg | 1,944.00 € |
Ref: IN-DA009CGX
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
